FINS // Angel Oak Financial Strategies Income Term Trust of
ANR <GO> NYSE RQD COCKPIT → CIK 0001745059 ↗ Financials • Finance/Investors Services
$11.93 ▲ +0.13
(+1.10%)
MKT CAP: $299.0M • VOL: 49.3K
52W L $12 52W H $13
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$10
MEDIAN
$13
MEAN
$14
HIGH
$16
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE FINS TAPE
FINS // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $14.44 | $13.72 | 2025-02-14 | $10.86 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $15.03 | $14.08 | 2025-02-06 | $11.21 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $13.60 | $13.12 | 2025-01-29 | $11.45 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $12.17 | — | 2025-01-17 | $11.69 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $10.50 | $11.33 | 2025-01-09 | $10.62 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $14.20 | $12.41 | 2024-12-18 | $10.38 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $11.57 | $12.05 | 2024-12-04 | $11.09 | -4.3% | 48% | C |